| [1] |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(1): 7-33.
|
| [2] |
Kang J, La Manna F, Bonollo F, et al. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer [J]. Cancer letters, 2022, 530: 156-69.
|
| [3] |
Park SH, Keller ET, Shiozawa Y. Bone marrow microenvironment as a regulator and therapeutic target for prostate cancer bone metastasis [J]. Calcif Tissue Int, 2018, 102(2): 152-62.
|
| [4] |
王欣文, 陈波, 李国兵, 等. RNF187在前列腺癌细胞中的表达及其对前列腺癌细胞增殖、侵袭的影响[J]. 新医学, 2023, 54(7): 480-486
|
| [5] |
Mcloughlin LC, O'kelly F, O'brien C, et al. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (spect-ct) to detect skeletal metastases from prostate cancer [J]. Ir J Med Sci, 2016, 185(1): 101-105.
|
| [6] |
Azad GK, Taylor B, Rubello D, et al. Molecular and functional imaging of bone metastases in breast and prostate cancers: an overview [J]. Clin Nucl Med, 2016, 41(1): e44-50.
|
| [7] |
Arscott WT, Tandle AT, Zhao S, et al. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration [J]. Transl Oncol, 2013, 6(6): 638-648.
|
| [8] |
李钧, 童哲, 魏勇, 等. Mir-125b靶向smad4调控非创伤性股骨头坏死骨髓基质干细胞成骨分化与增殖的相关性[J].中国老年学杂志, 2017, 37(2): 306-308.
|
| [9] |
孙珂焕, 朱晓峰, 杨丽, 等. 骨髓间充质干细胞外泌体在骨质疏松中的研究进展[J]. 中国骨质疏松杂志, 2019, 25(3): 393-398+415.
|
| [10] |
Yin L, Jiang LP, Shen QS, et al. Ncaph plays important roles in human colon cancer [J]. Cell Death Dis, 2017, 8(3): e2680.
|
| [11] |
Kobayashi T. Editorial comment to micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: regulation of ncaph by antitumor mir-199a/b-3p [J]. Int J Urol, 2019, 26(4): 521.
|
| [12] |
Jiang S, Chen H, He K, et al. Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the mir-99b-5p/igf1r axis [J]. Bioengineered, 2022, 13(2): 2004-2016.
|
| [13] |
Hu L, Xie X, Xue H, et al. Mir-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the rap1 signaling target adcy2 [J]. Exp Mol Med, 2022, 54(7): 961-72.
|
| [14] |
Li SL, An N, Liu B, et al. Exosomes from lncap cells promote osteoblast activity through mir-375 transfer [J]. Oncol Lett, 2019, 17(5): 4463-4473.
|
| [15] |
Yu L, Sui B, Fan W, et al. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring col1a1-targeting mirna-92a-1-5p [J]. J Extracell Vesicles, 2021, 10(3): e12056.
|
| [16] |
Zhang X, Sai B, Wang F, et al. Hypoxic bmsc-derived exosomal mirnas promote metastasis of lung cancer cells via stat3-induced emt [J]. Mol Cancer, 2019, 18(1): 40.
|
| [17] |
Jiang D, Wu X, Sun X, et al. Bone mesenchymal stem cell-derived exosomal microrna-7-5p inhibits progression of acute myeloid leukemia by targeting osbpl11 [J]. J Nanobiotechnology, 2022, 20(1): 29.
|
| [18] |
Amin AH, Sharifi LMA, Kakhharov AJ, et al. Role of acute myeloid leukemia (aml)-derived exosomes in tumor progression and survival [J]. Biomed Pharmacother, 2022, 150: 113009.
|
| [19] |
Jiang S, Mo C, Guo S, et al. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPH2 [J].J Exp Clin Cancer Res, 2019, 38(1): 495.
|
| [20] |
Chen HL, Li JJ, Jiang F, et al. Microrna-4461 derived from bone marrow mesenchymal stem cell exosomes inhibits tumorigenesis by downregulating copb2 expression in colorectal cancer [J]. Biosci Biotechnol Biochem, 2020, 84(2): 338-346.
|
| [21] |
Fu D, Liu B, Jiang H, et al. Bone marrow mesenchymal stem cells-derived exosomal microrna-19b-1-5p reduces proliferation and raises apoptosis of bladder cancer cells via targeting abl2 [J]. Genomics, 2021, 113(3): 1338-1348.
|
| [22] |
Zhen G, Wen C, Jia X, et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis [J]. Nat Med, 2013, 19(6): 704-12.
|
| [23] |
Diaz G, Melis M, Tice A, et al. Identification of micrornas specifically expressed in hepatitis c virus-associated hepatocellular carcinoma [J]. Int J Cancer, 2013, 133(4): 816-824.
|
| [24] |
Azzoni C, Bottarelli L, Pizzi S, et al. Xq25 and xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas [J]. Virchows Arch, 2006, 448(2): 119-126.
|
| [25] |
Liu W, Gong Q, Ling J, et al. Role of mir-424 on angiogenic potential in human dental pulp cells [J]. J Endod, 2014, 40(1): 76-82.
|
| [26] |
Shen X, Tang J, Hu J, et al. Mir-424 regulates monocytic differentiation of human leukemia u937 cells by directly targeting cdx2 [J]. Biotechnol Lett, 2013, 35(11): 1799-806.
|
| [27] |
Long XH, Mao JH, Peng AF, et al. Tumor suppressive microrna-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase [J]. Exp Ther Med, 2013, 5(4): 1048-1052.
|
| [28] |
Chen B, Duan L, Yin G, et al. Simultaneously expressed mir-424 and mir-381 synergistically suppress the proliferation and survival of renal cancer cells-cdc2 activity is up-regulated by targeting wee1 [J]. Clinics (Sao Paulo), 2013, 68(6): 825-833.
|
| [29] |
Zhang M, Zeng J, Zhao Z, et al. Loss of mir-424-3p, not mir-424-5p, confers chemoresistance through targeting yap1 in non-small cell lung cancer [J]. Mol Carcinog, 2017, 56(3): 821-832.
|
| [30] |
Bieg D, Sypniewski D, Nowak E, et al. Mir-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin [J]. Arch Gynecol Obstet, 2019, 299(4): 1077-1087.
|
| [31] |
Lu C, Wang H, Chen S, et al. Baicalein inhibits cell growth and increases cisplatin sensitivity of a549 and h460 cells via mir-424-3p and targeting pten/pi3k/akt pathway [J]. J Cell Mol Med, 2018, 22(4): 2478-2487.
|
| [32] |
Richardsen E, Andersen S, Al-saad S, et al. Low expression of mir-424-3p is highly correlated with clinical failure in prostate cancer [J]. Scientific reports, 2019, 9(1): 10662.
|